AI assistant
Aggreko Plc — Director's Dealing 2019
Mar 18, 2019
74738_rns_2019-03-18_2e04ad93-86d7-49ca-b84e-99002b0cdd88.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 1900T
Aggreko PLC
18 March 2019
18 March 2019
NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED ("PCA") WITH THEM
Aggreko PLC (the "Company") hereby announces that on 15 March 2019, Paola Hanna, the spouse of PDMR Ken Hanna, sold ordinary shares of 4 329/395 pence each in the Company.
This announcement is made in accordance with Article 19.3 of MAR
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Paola Hanna
2
Reason for the notification
a)
Position/status
Spouse (PCA) of Ken Hanna, Chairman
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Aggreko plc
b)
LEI
2138003R7TGCSVF27H47
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 4 329/395 pence each ('Shares')
GB00BK1PTB77
b)
Nature of the transaction
Sale of shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £7.38 | 3,569 |
d)
Aggregated information
- Aggregated volume
- Total
3,569
£26,339.22
e)
Date of the transaction
15 March 2019
f)
Place of the transaction
London Stock Exchange (XLON)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHDMGMFFRFGLZM